Top Markets
#1 DogBull DogBull +107.30%
#2 MarsCoin MarsCoin +62.81%
#3 Siacoin Siacoin +51.84%
#4 ADO Protocol ADO Protocol +51.50%
#5 Ontology Gas Ontology Gas +24.09%
#6 The Bitcoin Bull The Bitcoin Bull +17.18%
#7 Useless Coin Useless Coin +14.86%
#8 Apertum Apertum +14.84%
#9 Nockchain Nockchain +12.03%
#10 UnifAI Network UnifAI Network +11.58%
Coin of the day
DogBull DogBull
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Pozycja w akcjach #15300
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Cena akcji
$6.64
Ostatnia synchronizacja: 2026-08-31
Kapitalizacja rynkowa
$361.08M
Zmiana (1 dzień)
-0.82%
Zmiana (1 rok)
-61.27%
Kraj
US
Handel Upstream Bio, Inc. (UPB)

Kategoria

Healthcare
Historia ceny akcji dla Upstream Bio, Inc. (UPB)
Najwyższa cena zamknięcia: $6.99 dnia 2026-08-01

Najniższa cena zamknięcia: $24.44 dnia 2024-10-01
Historia cen akcji firmy Upstream Bio, Inc. od 2024 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -45.06%
2025 43.52%
2024 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.37 -11.93%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $750.16 5.14%
CH